ProShare Advisors’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-8,522
| Closed | -$409K | – | 1700 |
|
|
2020
Q1 | $409K | Sell |
8,522
-6,391
| -43% | -$307K | ﹤0.01% | 781 |
|
|
2019
Q4 | $700K | Sell |
14,913
-1,779
| -11% | -$83.5K | ﹤0.01% | 929 |
|
|
2019
Q3 | $395K | Buy |
16,692
+2,352
| +16% | +$55.7K | ﹤0.01% | 1082 |
|
|
2019
Q2 | $431K | Sell |
14,340
-1,988
| -12% | -$59.8K | ﹤0.01% | 1075 |
|
|
2019
Q1 | $366K | Buy |
16,328
+3,810
| +30% | +$85.4K | ﹤0.01% | 1161 |
|
|
2018
Q4 | $228K | Sell |
12,518
-2,438
| -16% | -$44.4K | ﹤0.01% | 1302 |
|
|
2018
Q3 | $271K | Sell |
14,956
-516
| -3% | -$9.35K | ﹤0.01% | 1422 |
|
|
2018
Q2 | $154K | Sell |
15,472
-938
| -6% | -$9.34K | ﹤0.01% | 1667 |
|
|
2018
Q1 | $87K | Buy |
16,410
+2,475
| +18% | +$13.1K | ﹤0.01% | 1648 |
|
|
2017
Q4 | $118K | Buy |
+13,935
| New | +$118K | ﹤0.01% | 1722 |
|